Citadel Advisors LLC 13D/13G Filings for Viridian Therapeutics, Inc. (VRDN)

Citadel Advisors LLC 13D and 13G filings for Viridian Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
06:19 am
Purchase
2021-12-3113GViridian Therapeutics, Inc.
VRDN
Citadel Advisors LLC943,340
4.300%
943,340increase
(New Position)
Filing